RaySearch Laboratories AB (publ) and C-RAD have recently formed a collaborative partnership to push the boundaries of radiation therapy. This collaboration aims to develop innovative solutions and products that will improve the quality of treatment for patients.
The focus of this partnership is to explore the integration of C-RAD’s surface scanning technologies into RayStation®*, RaySearch’s treatment planning system. Currently, C-RAD’s surface guided radiation therapy system, Catalyst+, is used for imaging and treatment. By incorporating Catalyst+ surfaces into RayStation, numerous potential applications can be realized.
One of the key applications of this collaboration is the ability to extend the field-of-view of a cone beam CT image. By utilizing information from surface scanning, the patient’s anatomy can be more accurately represented, leading to better clinical decision-making. This exciting application will be showcased at the ongoing trade show ESTRO, with further exploration of other potential applications in the future.
Cecilia de Leeuw, CEO, and President of C-RAD, expressed her enthusiasm for the collaboration, stating, “We are thrilled about the collaboration with RaySearch, where we will enhance and find new innovative solutions in our common fight against cancer.”
Johan Löf, founder, and CEO of RaySearch, also shared his excitement about working together with C-RAD, as both companies are based in Sweden. Löf highlighted the potential for surface scanning from Catalyst+ to significantly improve various steps in the radiation therapy treatment planning process within RayStation.
This collaboration agreement marks an important milestone in the field of radiation therapy, as two leading companies join forces to improve patient care and treatment outcomes. By combining their expertise and technologies, RaySearch and C-RAD are set to make a meaningful impact in the fight against cancer.
For more information about this collaboration, please contact Johan Löf, founder, and CEO of RaySearch Laboratories AB (publ), at +46 (0) 8 510 530 00 or via email at [email protected]
This press release is provided by Cision.
In addition to the information provided in the article, it is important to note some current market trends in radiation therapy.
Currently, there is a growing emphasis on personalized medicine and targeted therapies in cancer treatment. This is driving the demand for advanced radiation therapy techniques that can precisely target tumors while minimizing damage to healthy tissues. The integration of innovative solutions and products, such as the collaboration between RaySearch and C-RAD, can help meet this demand by improving treatment quality and accuracy.
Another trend in radiation therapy is the increasing adoption of surface-guided radiation therapy systems. These systems use surface scanning technologies, like C-RAD’s Catalyst+, to monitor and guide radiation treatment in real-time. This allows for more precise positioning of the patient and improves the accuracy of treatment delivery.
Looking ahead, the radiation therapy market is expected to experience significant growth in the coming years. According to a report by Grand View Research, the global radiation therapy market is projected to reach USD 10.1 billion by 2026, with a compound annual growth rate of 6.2% during the forecast period.
However, there are also key challenges and controversies associated with radiation therapy. One challenge is the potential side effects and long-term complications of radiation treatment. While radiation therapy is an effective treatment modality, it can cause tissue damage and lead to various complications, depending on the area being treated. Efforts are being made to minimize these side effects through advances in treatment planning and delivery techniques.
Controversies in radiation therapy include debates about the optimal treatment approach for certain types of cancer and the appropriate use of radiation in palliative care. These controversies highlight the need for ongoing research and collaboration, like the partnership between RaySearch and C-RAD, to improve treatment outcomes and address these challenges.
Advantages of the collaboration between RaySearch and C-RAD include the potential to enhance the accuracy and precision of radiation therapy treatment planning and delivery. By integrating C-RAD’s surface scanning technologies into RayStation, clinicians can have a better understanding of the patient’s anatomy and make more informed clinical decisions. This can lead to improved treatment outcomes and a higher quality of care for patients.
Disadvantages of the collaboration may include the need for additional training and resources to implement and utilize the integrated technologies effectively. Healthcare facilities may need to invest in new equipment and undergo training to fully benefit from the collaboration. There may also be cost considerations associated with the adoption of new technologies.
For more information about radiation therapy and its advancements, you can visit the American Society for Radiation Oncology (ASTRO) website at https://www.astro.org.